{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T07:36:21Z","timestamp":1648539381122},"reference-count":25,"publisher":"FapUNIFESP (SciELO)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Inst. Med. trop. S. Paulo"],"published-print":{"date-parts":[[1984,2]]},"abstract":"<jats:p>Noventa e quatro pacientes, 22 do sexo masculino e 72 do feminino, com idades variando de 11 a 71 anos, m\u00e9dia de 25, apresentando a forma hepatespl\u00eanica da esquistossomose mans\u00f4nica, foram tratados com uma nova droga antiesquistossom\u00f3tica \u2014 praziquantel \u2014 objetivando-se investigar sua efic\u00e1cia e toler\u00e2ncia. Duas doses orais \u2014 1 x 30 e 2 x 25 mg\/kg \u2014 foram comparadas. Efeitos colaterais foram verificados durante os primeiros dois dias seguintes \u00e0 administra\u00e7\u00e3o da droga, mas usualmente de m\u00e9dia intensidade e curta dura\u00e7\u00e3o. Os mais freq\u00fcentes e, por vezes, mais severos foram: dor ou desconforto abdominal, diarr\u00e9ia, tontura, cefal\u00e9ia e n\u00e1usea. Febre esteve presente em 19,2% dos casos e urticaria e prurido em dois pacientes. A investiga\u00e7\u00e3o laboratorial mostrou, em alguns casos, ligeiras altera\u00e7\u00f5es enzim\u00e1ticas (AST, ALT, \u03b3-GT) 24 horas ap\u00f3s a medica\u00e7\u00e3o. Nenhuma modifica\u00e7\u00e3o da urin\u00e1lise, da glicose sang\u00fc\u00ednea e dos dados hematol\u00f3gicos foi detectada, exceto o aumento comumente observado dos eosin\u00f3filos nos 7.\" e 30.\u00b0 dias, relacionado \u00e0 morte dos parasitas dentro do organismo. Da mesma forma, nenhuma anormalidade foi verificada no estudo eletroencefalogr\u00e1fico. Na eletrocardiografia, observou-se, em duas pacientes, uma ligeira e transit\u00f3ria altera\u00e7\u00e3o na repolariza\u00e7\u00e3o ventricular. No que diz respeito \u00e0 cura parasitol\u00f3gica, constatou-se, em 62 pacientes que conclu\u00edram seis meses de controle, um porcentual global de cura de 80,6%, sendo de 76,7% com a dose de 30 mg\/lkg e de 84,4% com a de 2 x 25 mg\/kg. Os pacientes n\u00e3o curados tiveram, por outro lado, uma acentuada redu\u00e7\u00e3o no n\u00famero de ovos do S. mansoni eliminados nas fezes. Al\u00e9m disso, cinco pacientes n\u00e3o curados, foram retratados seis ou mais meses depois, com a mesma dose inicial, obtendo-se 100\u00b0\/o de negatividade nos exames de fezes. Os Autores acreditam que com a administra\u00e7\u00e3o de doses um pouco mais altas como, por exemplo, 60 mg\/kg, se possa obter um maior porcentual de cura, sem preju\u00edzo da boa toler\u00e2ncia. A melhora cl\u00ednica e laboratorial a longo prazo, isto \u00e9, seis ou mais meses ap\u00f3s a medica\u00e7\u00e3o, foi marcante em todos os par\u00e2metros estudados.<\/jats:p>","DOI":"10.1590\/s0036-46651984000100007","type":"journal-article","created":{"date-parts":[[2013,4,18]],"date-time":"2013-04-18T07:06:35Z","timestamp":1366268795000},"page":"38-50","source":"Crossref","is-referenced-by-count":12,"title":["Tratamento da esquistossomose mans\u00f4nica hepatespl\u00eanica com praziquantel"],"prefix":"10.1590","volume":"26","author":[{"given":"Amaury D.","family":"Coutinho","sequence":"first","affiliation":[{"name":"Universidade Federal de Pernambuco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana L\u00facia C.","family":"Domingues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane N.","family":"Flor\u00eancio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzana T.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0165-1218(78)90002-2","article-title":"Absence of mutagenicity of praziquantel, a new, effective, anti-schistosomal agent, in bacteria, yeast, insects and mammalian cells","volume":"58","author":"BARTSCH H.","year":"1978","journal-title":"Mutation Research","ISSN":"http:\/\/id.crossref.org\/issn\/0921-8262","issn-type":"print"},{"key":"ref2","first-page":"10","article-title":"Experi\u00eancias cl\u00ednicas con praziquantel en el tratamiento de la Schistossomiasis mansoni","volume":"54","author":"BERTI J. J.","year":"1981","journal-title":"Tribuna Med. (Venezuela)"},{"key":"ref3","first-page":"315","article-title":"Double-blind clinical trial comparing praziquantel with oxamniquine in the treatment of patients with Schistosomiasis mansoni","volume":"24","author":"BRANCHINI M. L. M.","year":"1982","journal-title":"Rev. Inst. Med. trop. S\u00e3o Paulo"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF03189504","article-title":"Metabolism of praziquantel in man","volume":"3","author":"B\u00dcHRING K. U.","year":"1978","journal-title":"Eur. J. Drug Metb. Pharm."},{"key":"ref5","first-page":"180","article-title":"Tratamento com praziquantel de portadores de esquistossomose, em \u00e1rea end\u00eamica, com persist\u00eancia de positividade ap\u00f3s sucessivas administra\u00e7\u00f5es de oxamniquine","volume":"24","author":"CAMARGO S.","year":"1982","journal-title":"Rev. Inst. Med. trop. S\u00e3o Paulo"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1017\/S0022149X00005691","article-title":"The effect of praziquantel in Schistosoma mansoni","volume":"53","author":"COLES G. C","year":"1979","journal-title":"J. Helmint."},{"key":"ref7","first-page":"69","article-title":"Clinical-laboratory manifestations due to the death of worms after specific treatment of Schistosomiasis","volume":"11","author":"COUTINHO A.","year":"1975","journal-title":"Bras\u00edlia M\u00e9dica"},{"key":"ref8","series-title":"Livro de Gastrenterologia","volume-title":"Esquistossomiase mansoni","author":"COUTINHO A.","year":"1981"},{"key":"ref9","first-page":"773","article-title":"Initial experiences with praziquantel in the treatment of human infections due to Schistosoma haematobium","volume":"57","author":"DAVIS A.","year":"1979","journal-title":"Bull. WId. Hlth. Org."},{"key":"ref10","first-page":"555","article-title":"Toxicological profile of praziquantel, a new drug against cestode and schistosoma infections, as compared to some other schistosomicides","volume":"31","author":"FROHBERG H.","year":"1981","journal-title":"Arzneim. Forsch."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF00389899","article-title":"Praziquantel, a new broad-spectrum antischistosomal agent","volume":"52","author":"GONNERT R.","year":"1977","journal-title":"Z. Parasitenk."},{"key":"ref12","first-page":"787","article-title":"Double-blind studies of tolerance to praziquantel in Japanese patients with Schistosoma japonicum infections","volume":"57","author":"ISHIZAKI T.","year":"1979","journal-title":"Bull. Wld. Hlth. Org."},{"key":"ref13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF00389902","article-title":"The susceptibility to praziquantel of Schistosoma haematobium in vervet monkey (Cercopithecus aethiope)","volume":"52","author":"JAMES C","year":"1977","journal-title":"Z. Parasitenk."},{"key":"ref14","first-page":"397","article-title":"A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni","volume":"14","author":"KATZ N.","year":"1972","journal-title":"Rev. Inst. Med. trop. S\u00e3o Paulo"},{"key":"ref15","first-page":"781","article-title":"Preliminary trials with praziquantel in human infections due to Schistosoma mansoni","volume":"57","author":"KATZ N.","year":"1979","journal-title":"Bull. Wld. Hlth. Org."},{"key":"ref16","first-page":"72","article-title":"Clinical trials with praziquantel in Schistosomiasis mansoni","volume":"23","author":"KATZ N.","year":"1981","journal-title":"Rev. Inst. Med. trop. S\u00e3o Paulo"},{"key":"ref17","first-page":"310","article-title":"Double-blind clinical trial comparing praziquantel with oxamniquine in Schistosomiasis mansoni","volume":"24","author":"KATZ N.","year":"1982","journal-title":"Rev. Inst. Med. trop. S\u00e3o Paulo"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00560463","article-title":"Clinical pharmacology in normal volunteers of praziquantel, a new drug against schistosomes and cestodes","volume":"14","author":"LEOPOLD G.","year":"1978","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF00368227","article-title":"Mutagenicity studies with praziquantel, a new anthelmintic drug in mammalian systems","volume":"39","author":"MACHEMER L.","year":"1978","journal-title":"Arch. Toxicol."},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1136\/bmj.2.6202.1396","article-title":"Praziquantel: a new schistosomicide against Schistosome haematobium","volume":"2","author":"McMAHON J. E.","year":"1979","journal-title":"Brit. Med. J.","ISSN":"http:\/\/id.crossref.org\/issn\/0267-0623","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF00293649","article-title":"Mutagenicity studies with praziquantel, a new anthelmintic drug: tissue, host and urine-mediated mutagenicity assays","volume":"38","author":"OBERMEIER J.","year":"1977","journal-title":"Arch. Toxicol."},{"key":"ref22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF00389900","article-title":"Experimental chemotherapy of Schistosomiasis mansoni","volume":"52","author":"PELLEGRINO J.","year":"1977","journal-title":"Z. Parasitenk."},{"key":"ref23","first-page":"793","article-title":"Preliminary clinical trials with praziquantel in Schistosoma japonicum infections in the Philippines","volume":"57","author":"SANTOS A. T.","year":"1979","journal-title":"Bull. Wld. Hlth. Org."},{"key":"ref24","first-page":"601","article-title":"Praziquantel in the treatment of the hepatosplenic form of Schistosomiasis mansoni","volume":"31","author":"SILVA L. C. da","year":"1981","journal-title":"Drug Res"},{"key":"ref25","first-page":"601","article-title":"A comparison of the susceptibility to praziquantel of Schistosoma haematobium, S. japonicum, S. mansoni, S. intercalatum and mansoni","volume":"31","author":"WEBBE C.","year":"1981","journal-title":"Drug. Res."}],"container-title":["Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rimtsp\/v26n1\/07.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,27]],"date-time":"2017-05-27T12:42:08Z","timestamp":1495888928000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0036-46651984000100007&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,2]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1984,2]]}},"alternative-id":["S0036-46651984000100007"],"URL":"https:\/\/doi.org\/10.1590\/s0036-46651984000100007","relation":{},"ISSN":["0036-4665"],"issn-type":[{"value":"0036-4665","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984,2]]}}}